BIONEXT
The Bionext® wound healing product is a Class III medical device with the equivalent of a 510K Clearance in Latin America.  The Bionext® product was developed to address key problems with current wound dressing technologies. Specifically: pain, infection, and inefficiency of changing wound dressing and overall cost to the healthcare system are all bi-products of suboptimal wound protection and treatment systems.  The Bionext® product protects and treats post-traumatic wounds and can easily be used at “in-the field triage centers”, outpatient clinics, hospitals, emergency rooms or a physician’s office without the need for surgery or complicated procedures.  The Bionext® technology deploys a bacterial biocellulose film to catalyze and accelerate wound healing through dermal cell regeneration. This biocellulose film (BF) is synthesized by Acetobacter xylinum bacteria and has been clinically proven to aid in wound healing. It is a biocompatible dressing that temporarily replaces the skin in lesions caused by burns, trauma and chronic ulcers associated to venous insufficiency, diabetes and other diseases.